Screener
Eligibility screening
Compare Petosemtamab with Investigator's Choice Monotherapy in Patients with Previously Treated Head and Neck Squamous Cell Carcinoma
58 US sites in AL, AZ, CA, CO +25
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.